Gates Foundation Strategic Investment Fund Logo
Share this page:

Press Release: Visterra secures financing from Gates Foundation and Omega to close $26M Series A financing


November 9, 2012

Visterra, Inc., developer of novel medicines to prevent and treat infectious and other major diseases, today announced that it has raised an additional $13M to complete a $26M Series A financing. The Bill & Melinda Gates Foundation and Omega Funds participated with the existing investors – Polaris Venture Partners, Flagship Ventures and Lux Capital.

Read the full text here.